13F HOLDINGS REPORT (Amended)
Eversept Partners, LP
Quarter ended Q4 2023 · Filed November 8, 2023 · Accession 0001697013-23-000025
Total Value
$5.3M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | EDITAS MEDICINE INC | EDIT | 90,000 | $3.7M | 69.60% |
| 2 | ACADIA PHARMACEUTICALS INC | ACAD | 84,600 | $1.4M | 26.45% |
| 3 | FORTE BIOSCIENCES INC | FBRX | 70,700 | $209,700 | 3.95% |